Gilead Asks FDA To Retract ‘Uncommon Condition’ Standing For Coronavirus Medicine Remdesivir: Shots

0
0

Loading ....
 

After the FDA gave Gilead Sciences orphan medication standing for its speculative medication remdesivir Tuesday, Gilead asked that the firm retract that standing Wednesday.
Bloomberg/Bloomberg using Getty Images
In an unusual turnabout, drugmaker Gilead Sciences aske …
Read More

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here